Carla Grandori

Carla Grandori

Founder and President and Scientific Director at Cure First
Seattle, Washington, United States

Carla Grandori is Founder and President and Scientific Director at Cure First. She was VP head of Functional Clinical Modeling and Functional Genomics, Tempus AI Inc at Tempus AI and Chief Executive Officer at SEngine Precision Medicine. She was Research Member at Fred Hutch and Director at University of Washington. She is Leader, MYC Pathway, at the TCGA Pan-Cancer Analysis Project and Steering Committee Member at the Cancer Target Discovery & Development (CTD²) Network.

  • Cure First Founder and President and Scientific Director 2025–present, Scientific Director 2014–present, President 2012–2025 · current
  • Tempus AI VP head of Functional Clinical Modeling and Functional Genomics, Tempus AI Inc 2023–2024 · past
  • SEngine Precision Medicine Chief Executive Officer 2015–2023 · past
  • Fred Hutch logo
    Fred Hutch Research Member 2012–2014, Affiliate Investigator 2009–2012, Staff-Scientist 1998–2006, Post-Doctoral Fellow 1991–1998 · past
  • University of Washington logo
    University of Washington Director 2009–2012, Reasearch Associate Professor 2009–2012 · past
  • Merck Research Fellow 2006–2008 · past
  • Rosetta Inpharmatics, LLC/Merck & Co., Inc. Research fellow 2006–2008 · past
  • MIT Post-Doctoral Fellow 1989–1991 · past

Education

  • Massachusetts Institute of Technology Post-doctoral fellow, Cell/Cellular and Molecular Biology · 1989–1991
  • The Rockefeller University Doctor of Philosophy - PhD, Biochemistry and Molecular Biology · 1984–1990
  • Sapienza Università di Roma Doctor of Medicine - MD · 1976–1982

Online